Watermark

BGB-A317-310

Active, not recruiting

Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-310

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20190543

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

No Study Documents